These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 9165065

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Focalized matrix proteolysis and inflammation].
    Gaudin P, Trocmé C, Monier F, Zaoui P, Barro C, Polack B, Hadjian A, Berthier S, Morel F.
    Ann Biol Clin (Paris); 1998; 56(6):661-9. PubMed ID: 9853025
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of matrix metalloproteinases leads to lethality in transgenic Xenopus laevis: implications for tissue-dependent functions of matrix metalloproteinases during late embryonic development.
    Damjanovski S, Amano T, Li Q, Pei D, Shi YB.
    Dev Dyn; 2001 May; 221(1):37-47. PubMed ID: 11357192
    [Abstract] [Full Text] [Related]

  • 4. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease.
    Ries C, Petrides PE.
    Biol Chem Hoppe Seyler; 1995 Jun; 376(6):345-55. PubMed ID: 7576228
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.
    Fernandez-Catalan C, Bode W, Huber R, Turk D, Calvete JJ, Lichte A, Tschesche H, Maskos K.
    EMBO J; 1998 Sep 01; 17(17):5238-48. PubMed ID: 9724659
    [Abstract] [Full Text] [Related]

  • 8. Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2.
    Deryugina EI, Bourdon MA, Reisfeld RA, Strongin A.
    Cancer Res; 1998 Aug 15; 58(16):3743-50. PubMed ID: 9721888
    [Abstract] [Full Text] [Related]

  • 9. Structure and function of matrix metalloproteinases and TIMPs.
    Nagase H, Visse R, Murphy G.
    Cardiovasc Res; 2006 Feb 15; 69(3):562-73. PubMed ID: 16405877
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Activation of pro-MMP-2 mediated by MT1-MMP in human salivary gland carcinomas: possible regulation of pro-MMP-2 activation by TIMP-2.
    Kayano K, Shimada T, Shinomiya T, Nakai S, Hisa Y, Aoki T, Seiki M, Okada Y.
    J Pathol; 2004 Apr 15; 202(4):403-11. PubMed ID: 15095267
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
    Visse R, Nagase H.
    Circ Res; 2003 May 02; 92(8):827-39. PubMed ID: 12730128
    [Abstract] [Full Text] [Related]

  • 15. Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion.
    Sato H, Okada Y, Seiki M.
    Thromb Haemost; 1997 Jul 02; 78(1):497-500. PubMed ID: 9198203
    [Abstract] [Full Text] [Related]

  • 16. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
    Jo Y, Yeon J, Kim HJ, Lee ST.
    Biochem J; 2000 Feb 01; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
    [Abstract] [Full Text] [Related]

  • 17. What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models?
    Janssens S, Lijnen HR.
    Cardiovasc Res; 2006 Feb 15; 69(3):585-94. PubMed ID: 16426591
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.